BRAF and central nervous system cancer: Care should be taken in generalizing this OS too broadly as our population had 3 IDH-mutant gliomas, and one who had a silent IDH mutation, BRAF and three-year survival, suggesting the possibility of alternative pathology such as epithelioid GBM or PXA.